CD4 and cancer: Kristensen et al. [16] previously tested similar CD4+- and CD8+-specific PET tracers but radiolabeled with zirconium-89, [89Zr]Zr-DFO-CD4 and [89Zr]Zr-DFO-CD8a, in several preclinical mouse models of cancer.